FDA's rushed AI tool, Elsa, gives inaccurate information

The FDA's new agency-wide AI tool, Elsa, was released prematurely and is reportedly providing inaccurate information. This has raised concerns about its reliability. The large language model, designed to assist FDA employees, was rolled out ahead of schedule. Staff testing revealed Elsa generated incorrect summaries of FDA-approved products and public information. The FDA touted Elsa's ability to accelerate reviews and evaluations. The tool's rapid deployment, however, has been criticized by staff who found it to be rushed and buggy.